A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)

NCT05769816 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
120
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Second Affiliated Hospital of Chongqing Medical University

Collaborators